(Q40487305)

21 September 2017

title

Quality of life in common variable immunodeficiency requiring intravenous immunoglobulin therapy (English)

1 reference

common variable immunodeficiency

21 September 2017

1 reference

1 reference

Robert Hostoffer

3

0 references

author name string

Haig Tcheurekdjian

series ordinal

1

1 reference

21 September 2017

Tonya Palermo

series ordinal

2

1 reference

21 September 2017

publication date

1 August 2004

1 reference

Annals of Allergy, Asthma & Immunology

21 September 2017

published in

1 reference

21 September 2017

volume

93

1 reference

21 September 2017

issue

2

1 reference

21 September 2017

page(s)

160-165

1 reference

The measurement of quality of life in children: past and future perspectives

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961469-X

7 January 2021

Measuring health-related quality of life

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961469-X

7 January 2021

Quality of life measurement: bibliographic study of patient assessed health outcome measures

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961469-X

7 January 2021

Immunoglobulin substitution therapy in a patient with primary hypogammaglobulinaemia and anti-IgA antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961469-X

7 January 2021

The life situations of patients with primary antibody deficiency untreated or treated with subcutaneous gammaglobulin infusions.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961469-X

7 January 2021

Common variable immunodeficiency: clinical and immunological features of 248 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961469-X

7 January 2021

Immunoglobulin replacement treatment by rapid subcutaneous infusion

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961469-X

7 January 2021

Intravenous immunoglobulin, splenectomy, and antibiotic prophylaxis in Wiskott-Aldrich syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961469-X

7 January 2021

Quality of life in asthma. I. Internal consistency and validity of the SF-36 questionnaire.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961469-X

7 January 2021

The SF-36 as a health status measure for epilepsy: a psychometric assessment

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961469-X

7 January 2021

The SF36 health survey questionnaire: an outcome measure suitable for routine use within the NHS?

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961469-X

7 January 2021

The Medical Outcomes Study. An application of methods for monitoring the results of medical care

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961469-X

7 January 2021

Functional status and well-being of patients with chronic conditions. Results from the Medical Outcomes Study

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961469-X

7 January 2021

Natural history of peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961469-X

7 January 2021

Adverse reactions of prophylactic intravenous immunoglobulin infusions in Iranian patients with primary immunodeficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961469-X

7 January 2021

Disturbed neuroendocrine-immune interactions in chronic fatigue syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961469-X

7 January 2021

10.1016/S1081-1206(10)61469-X

Identifiers

DOI

1 reference

21 September 2017

1 reference